What is Coherus BioSciences Inc?
, a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin IL-27. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 57.15M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.